News

Meet alum Patrick O'Brien, PharmD '89, JD '93, general counsel for Arrowhead Pharmaceuticals.

A recent HOPE Center study estimated total lifetime costs of valley fever in Arizona at $736 million. 

Expenses for the fungal disease can skyrocket for people whose diagnosis is delayed, leading to more serious infection or death.

Economic benefits associated with statin adherence were observed within a one-year period for a large cohort of adult statin users with commercial health plans.

The main purpose of the board is to build student excitement around the College of Pharmacy.

Read about the latest publications, achievements and more from the College's faculty members!

Read about the latest publications, achievements and more from the College's faculty members!

Results support use of a motivation-and-work-performance questionnaire across medication management center (MMC) sites nationwide.

The award will be presented to Dean Schnellmann during the UArizona Foundation’s Board of Trustees meeting.

Read about the latest publications, achievements and more from the College's faculty members!

Read about the latest publications, achievements and more from the College's faculty members!

The current issue of Journal of Managed Care & Specialty Pharmacy (JMCP) features a 2017 HOPE Center study as one of the most significant topics in the field over the past 25 years.

Medication adherence among those taking statins was related to better disease control, less inpatient and outpatient visits and costs, and lower costs overall despite having higher prescription drug costs.

Laurence Hurley, PhD, and Robert Norwood, PhD, have been elected as fellows of the academy, the organization's most prestigious designation.

Read about the latest publications, achievements and more from the College's faculty members!

Results suggest significant monetized benefit with use of adjunctive hydrocortisone therapy in critically ill patients with septic shock.

Study warns it is not possible to use CPT codes to identify all patients receiving MTM services. Raises call for more accurate claims analysis methods to identify MTM use and its effects on patient outcomes.